An aminoglycoside dosing regimen in a morbidly obese patient

Abstract

Get full access to this article

View all access options for this article.

References

BLOUIN

, MANN

, GRIFFEN

, BAUER

, RECORD

. Tobramycin pharmacokinetics in morbidly obese patients. Clin Pharmacol Ther 1979; 26: 508–12.

ABERNETHY

, GREENBLATT

. Drug disposition in obese humans. An update. Clin Pharmacokinet 1986; 11: 199–213.

BAUER

, EDWARDS

, DELLINGER

, SIMONOWITZ

. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol 1983; 24: 643–7.

CORCORAN

, SALAZAR

, SCHENTAG

. Excessive aminoglycoside nephrotoxicity in obese patients (letter). Am J Med 1988; 85: 279.

SCHWARTZ

, PAZIN

, LYON

, HO

, PASCULLE

. A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. J Infect Dis 1978; 138: 499–595.

BAUER

, BLOUIN

, GRIFFEN

, RECORD

, BELL

. Amikacin pharmacokinetics in morbidly obese patients. Am J Hosp Pharm 1980; 37: 519–22.

SCHENTAG

, ADELMAN

. A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic model. Drug Intell Clin Pharm 1983; 17: 528–31.

VOYTOVICH

, OUTTEN

. An aminoglycoside monitoring service in a community hospital using a microcomputer. Hosp Pharm 1987; 22: 267–72.